Fundraising FoxEntasistx
1 known investors
Find your way into Entasistx
Sign up to see every warm intro you have to Entasistx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Entasistx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Entasis Therapeutics is a biotechnology company developing and marketing therapies for critical care and infectious diseases, focusing on serious conditions with high unmet need. Its products include GIAPREZA, NUZOLVENCE, XACDURO, XERAVA, and ZEVTERA.
Investors · 1
Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Entasistx do?
- Entasis Therapeutics is a biotechnology company developing and marketing therapies for critical care and infectious diseases, focusing on serious conditions with high unmet need. Its products include GIAPREZA, NUZOLVENCE, XACDURO, XERAVA, and ZEVTERA.
- Who are Entasistx's investors?
- Entasistx's investors include Sofinnova Ventures.